Meadows J, et al. - This work was designed to assess whether low body mass index (BMI) was associated with prescription of transdermal fentanyl at q48h dosing frequency. Researchers observed that lower BMI was associated with q48h fentanyl patch dosing, suggesting that in cancer patients, it could also be associated with end-of-dose failure. They recommended closely monitoring and alerting these patients to this possibility.